When was Keimed founded?

Keimed was founded in 2000 and raised its 1st funding round 15 years after it was founded.

Where is Keimed located?

Keimed is headquartered in Hyderabad, India. It is registered at 19 Bishop Gardens, R A Puram, Chennai, Ramakrishna Nagar (Chennai), Chennai, Chennai City Corporation, Tamil Nadu, India, 600028.

Who is the current CEO of Keimed?

Gaurav Chaturvedi and Gaurav Chaturvedi s of Keimed.

Which legal entities is Keimed associated with?

Keimed is associated with Keimed Private Limited and 4 others.

How many employees does Keimed have?

As of Mar 31, 2025, Keimed has 588 employees, reflecting a 68% year-over-year growth in headcount.

Is Keimed a funded company?

Keimed is a funded company, having raised a total of $16.6M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Aug 13, 2015.

How much is Keimed worth?

The latest valuation of Keimed is $***** as of Mar 20, 2025.

When was the latest funding round of Keimed?

Keimed's latest funding was a $***** Series B round on Mar 20, 2025, with participation from 1 investor.

What is the annual revenue of Keimed?

Annual revenue of Keimed is more than ₹1,000 Cr as on Mar 31, 2025

Where does Keimed rank among its competitors?

Keimed ranks 3rd amongst 1290 active competitors, of which 4 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Keimed, which secured $11.7M in Mar, 2025.

Who are the top competitors of Keimed?

Keimed's top competitors include Entero Healthcare, AmerisourceBergen and Sayre Therapeutics. Among them, Keimed secured the most recent funding round in March, 2025.

Keimed - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Pharmaceutical distributor of temperature-sensitive medicines. It sources products directly from manufacturers and maintains storage facilities, ensuring quality and effectiveness. The company utilizes a rapid logistics system for swift and precise delivery. Its advanced cold chain infrastructure and technology support seamless operations and maximize efficiency.

Website: keimed.com
Registered Address: 19 Bishop Gardens, R A Puram, Chennai, Ramakrishna Nagar (Chennai), Chennai, Chennai City Corporation, Tamil Nadu, India, 600028

Key Metrics

Founded Year

2000

Location

Hyderabad, India

Stage

Series B

Total Funding

$16.6M in 2 rounds

Latest Funding Round

Series B, Mar 20, 2025, $*****

Post Money Valuation

$***** as on Mar 20, 2025

Investors

Apollo Hospitals & 3 more

Ranked

3^rd among 1290 active competitors

Annual Revenue

₹1,000+ Cr as on Mar 31, 2025

Employee Count

588 as on Mar 31, 2025

Similar Companies

Entero Healthcare & 4837 more

View Keimed's full profile

Keimed is associated with 5 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
ADELINE PHARMACEUTICALS PRIVATE LIMITED CIN: U51397WB2022PTC252369 , India, Active	Mar 21, 2022	₹100 - ₹500 Cr (As on Mar 31, 2025)	-
Kamineni Enterprises International Llp CIN: ABC-9374 , India, Active	Nov 07, 2022	₹10 - ₹50 Cr (As on Mar 31, 2025)	-
Keimed Private Limited CIN: U72200TN2000PTC179280 , India, Active	Mar 10, 2000	₹1,000+ Cr (As on Mar 31, 2025)	384 (As on Apr 01, 2026)
LAKSHMI ANNAPURNA MEDICAL DISTRIBUTORS PRIVATE LIMITED CIN: U24230AP2021PTC119065 , India, Active	Aug 06, 2021	₹10 - ₹50 Cr (As on Mar 31, 2025)	-
AUSPHARMA PRIVATE LIMITED CIN: U24304TG2020PTC143079 , India, Active	Aug 22, 2020	₹500 - ₹1,000 Cr (As on Mar 31, 2025)	-

Keimed has raised a total funding of $16.6M over 2 rounds. Its first funding round was on Aug 13, 2015. Its latest funding round was a Series B round on Mar 20, 2025 for $*****. 1 investor participated in its latest round. Keimed has 4 institutional investors.

Here is the list of recent funding rounds of Keimed:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 20, 2025	5994670	Series B	1508068	7664248	9283698	3327596
Aug 13, 2015	9322689	Series A	6934503	4024003	Mitsui	6165603

Access funding benchmarks and valuations. Sign up today!

View details of Keimed's funding rounds and investors

Here are the details of Keimed's key team members:

Gaurav Chaturvedi: CEO of Keimed.
Contact Info: 1 email address
Gaurav Chaturvedi: CEO of Keimed.
Contact Info: 1 email address and 1 phone number

Keimed's Board of Directors

Keimed's board has 4 active members. Shobana Kamineni and Arvind Kumar Kumar Venkat are part of team and Raj Shankar and Puansh Kamineni are independent board members.

Here is the list of Keimed's board of directors:

Name	Type	Representing	Status	Duration
Shobana Kamineni	Team	-	Current	18y 3m
{dgnwfh	Team	-	Current	5y 2m
Raj Shankar	Independent board member	-	Current	2y 11m
nl{pkga	Independent board member	-	Current	3y 6m

View details of Keimed's Founder profiles and Board Members

Keimed's employee count trend

Keimed has 588 employees as of Mar 25. The total employee count is 68.0% more than what it was in Mar 24. Here is Keimed's employee count trend over the years:

Uncover Keimed's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Keimed include Entero Healthcare, AmerisourceBergen and Sayre Therapeutics. Here is the list of Top 10 competitors of Keimed, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Entero Healthcare 2018, Mumbai (India), Public	Provider of integrated healthcare product distribution solutions for manufacturers and pharmacies	$59.7M	Orbimed, Millennium Medicare & 38 others	71/100
2nd	AmerisourceBergen 1985, Chesterbrook (United States), Public	Drug Corporation	-	nextGENE Capital, Walgreens Boots Alliance ... & 4 others	68/100
3rd	Keimed 2000, Hyderabad (India), Series B	Pharmaceutical distributor of temperature-sensitive medicines	$16.6M	Mitsui, Apollo Hospitals & 2 others	50/100
4th	Sayre Therapeutics 2015, Bengaluru (India), Series A	Provider of access to innovative therapies for rare and life-threatening diseases	$7.9M	Accel, Aarin Capital & 1 others	47/100
5th	Suresh Pharma Agencies 2009, Chennai (India), Unfunded	Distributor and supplier of pharmaceutical products to customers	-	-	43/100
6th	Flagship Biotech 2008, Mumbai (India), Unfunded	Manufacturer of injectable, oral, and topical pharmaceutical formulations	-	-	42/100
7th	Speciality Medicines 2021, Mumbai (India), Public	Distributor & manufacturer of pharmaceutical medicines	-	-	41/100
8th	Hospimax Healthcare 2009, Delhi (India), Unfunded	Distributor of pharmaceutical products	-	-	41/100
9th	Neelkanth Drugs 1989, Delhi (India), Unfunded	Distributor of pharmaceutical products	-	-	40/100
10th	Gujarat Terce Laboratories 1985, Gandhinagar (India), Public	Manufacturer of pharmaceutical products across multiple therapeutic areas for global distribution	-	-	40/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Keimed's competitors? Click here to see the top ones

Founders own 12.73%, Funds own 0.00%, Parent Entities own 17.31% and Enterprises (largest shareholder) own 27.31%. The net worth of Keimed's founders is INR 825Cr as of Mar 20, 2025.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	12.73%	825Cr	1672878	9160292	9416826	5336678
Fund	-	0	0	0	0	0
Mitsui	0	0	0	0	0	0
Parent Entity	17.31%	1,120Cr	2279834	9131218	9662186	6894607
Enterprise	27.31%	1,770Cr	1985102	9480976	1225610	3083669
Other People	42.65%	2,770Cr	6628762	5593042	9396832	1349802
Total	100.00%	6,480Cr	3876422	1470697	2125034	2143992